EMBECTA CORP. - COMMON

embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day

22 May 2025 03:30:00 By Nasdaq GlobeNewswire

Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results

09 May 2025 03:30:00 By Nasdaq GlobeNewswire

embecta Announces Quarterly Cash Dividend

09 May 2025 03:00:00 By Nasdaq GlobeNewswire

Embecta to host Analyst and Investor Day on May 22, 2025

28 Apr 2025 04:30:00 By Nasdaq GlobeNewswire

embecta to Report Fiscal Second Quarter 2025 Financial Results

21 Apr 2025 14:00:00 By Nasdaq GlobeNewswire

Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations

01 Apr 2025 05:05:00 By Nasdaq GlobeNewswire

embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference

18 Feb 2025 14:00:00 By Nasdaq GlobeNewswire

Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results

06 Feb 2025 03:30:00 By Nasdaq GlobeNewswire

embecta Announces Quarterly Cash Dividend

06 Feb 2025 03:00:00 By Nasdaq GlobeNewswire

embecta to Report Fiscal First Quarter 2025 Financial Results

23 Jan 2025 14:00:00 By Nasdaq GlobeNewswire

embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

19 Dec 2024 14:00:00 By Nasdaq GlobeNewswire

Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs

26 Nov 2024 03:30:00 By Nasdaq GlobeNewswire

embecta Announces Quarterly Cash Dividend

26 Nov 2024 03:00:00 By Nasdaq GlobeNewswire

UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

12 Nov 2024 14:31:55 By Nasdaq GlobeNewswire

embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

12 Nov 2024 14:00:00 By Nasdaq GlobeNewswire

embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell

07 Nov 2024 03:30:00 By Nasdaq GlobeNewswire

embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes

03 Sep 2024 03:30:00 By Nasdaq GlobeNewswire

embecta to Participate in Investor Events

22 Aug 2024 14:00:00 By Nasdaq GlobeNewswire

Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results

09 Aug 2024 03:30:00 By Nasdaq GlobeNewswire

embecta Announces Quarterly Cash Dividend

09 Aug 2024 03:00:00 By Nasdaq GlobeNewswire